Investor's Business Daily on MSN
TG Therapeutics Crumbles After Roche Unveils Its 'Unprecedented' Test Results
Roche presented "unprecedented" test results for its multiple sclerosis treatment, putting pressure on key rival TG ...
TORONTO, Nov. 10, 2025 /CNW/ - Geneseeq Technology Inc., a global precision oncology company, today announced its PanTRKare™NTRK1/NTRK2/NTRK3 Gene Fusion Detection Kit has received marketing authoriza ...
Roche’s fenebrutinib shows unprecedented positive phase III results as the potential first and only BTK inhibitor in both relapsing and primary progressive multiple sclerosis ...
Help Jack Curtis fulfill a dream that seemed beyond impossible. Curtis has Stage 2 Hodgkin’s lymphoma. He is also a college quarterback. Typically, the first circumstance would at least temporarily ...
The first (FENhance 2) of two pivotal RMS studies met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses compared to teriflunomideIn a pivotal PPMS study ...
Preliminary research led by ophthalmologist Jesse Smith, MD, indicates that a virtual reality-based vision test was as accurate as a standard test among patients with geographic atrophy, a potentially ...
The third-ranked Iowa Central wrestling team opened their dual season with a lopsided 44-4 victory over No. 10 Iowa Lakes on Wednesday night. The Tritons took all but one bout versus the Lakers. In ...
Inside Chevron Phillips Chemical’s pursuit to build not just the largest, but the safest ethylene and polyethylene facilities in the world.
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...
SMi Systems, a leading innovator in single-molecule detection for drug discovery and diagnostics, announces the appointment ...
Detailed price information for Cellbxhealth Plc ADR (ANPCY) from The Globe and Mail including charting and trades.
The inaugural Genetic Agency Technology Conference (GATC) gathered a group of researchers and entrepreneurs to discuss the vision for AI-based genetic medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results